Review5-HT receptors and reward-related behaviour: A review
Highlights
► Serotonin (5-HT) is a key regulator of reward-related behaviours. ► 5-HT's effects cannot be generalized in reward. ► All 5-HT receptor subtypes are likely involved. ► Content (e.g. receptor subtype, localization, selective ligands) is important. ► As is context (e.g. behavioural model type and precise parameters used).
Introduction
In its most basic form, a reward (an object or event, regardless of its origin) is something that an organism will expend energy to obtain or approach; in this context, it is operationally opposite to an aversive stimulus (e.g. Wise, 2004). A rich animal literature has shown that the brain neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) plays an important role in the regulation of reward-related processing. For instance, 5-HT is involved in natural reward-related physiology and behaviour, from feeding to sexual activity (for reviews, see Pfaus, 2009, Wirtshafter, 2001). Recent studies in humans have supported this notion, showing for instance that 5-HT is involved in emotional regulation (see Cools et al., 2008 for review) and experiences as varied as the pleasantness of warmth (Lowry et al., 2009) or chocolate (McCabe et al., 2010).
Given 5-HT's role in reward-related functioning (Kranz et al., 2010), and that altered reward processing has been proposed in many psychiatric disorders (as reflected, for instance, by reduced motivation to obtain rewards in depression and schizophrenia), it should not be surprising that serotonergic dysfunction has been associated with numerous neuropsychiatric pathologies and, as such, has been a main target for therapeutic drug development. Most notably, extensive research has implicated this system in depression (e.g. a typical first-line treatment is the use of selective serotonergic reuptake inhibitors) (Trivedi et al., 2006), anxiety (Hood et al., 2010), schizophrenia (Emsley, 2009) and addiction (Rothman et al., 2008). Nonetheless, there is an incomplete understanding of the pharmacological mechanisms underlying the role of 5-HT in reward-related processing; this is necessary for a full understanding of both healthy and pathological reward system functioning and for the development of future effective drug therapies for disorders that entail dysfunction of brain reward systems.
Serotonin-containing neurons make extensive connections to other neural systems in reward-related brain areas. Clusters of serotonergic cell bodies are divided into nine nuclei or cell groups (B1–B9) (Dahlstrom and Fuxe, 1964) along the midline (or raphe) from the medulla to the midbrain. The primary ascending projections originate from the anterior (i.e. dorsal and median) raphe nuclei and account for the majority of 5-HT innervation of the forebrain (Azmitia and Segal, 1978). Innervation by these anterior raphe nuclei is extensive, diffuse, and overlapping, and includes areas known to be involved in aversion- and reward-related regulation such as the nucleus accumbens septi (NAc), ventral tegmental area (VTA), substantia nigra, hippocampus, amygdala, and prefrontal cortex (Hensler, 2006, Ikemoto, 2010, Lechin et al., 2006). In addition to having reciprocal connections with many reward-related brain areas, 5-HT regulates the transmission of all major neurotransmitters (Fink and Gothert, 2007), including the well-studied dopamine (Alex and Pehek, 2007). In a recent review by Kranz et al. (2010), the authors present converging evidence, particularly from pharmacology, electrophysiology, and human brain imaging, that the 5-HT system is as important for reward processing as dopamine. The current review focuses on the specific putative roles of individual 5-HT receptor subtypes in this processing.
The idea that 5-HT may be involved in the regulation of reward-related behaviours likely began with the work of James Olds and his colleagues. They showed that rats decreased their motivated responding following lateral hypothalamic microinjections of 5-HT (Olds et al., 1964), about a decade following their discovery that rats would self-administer electrical stimulation into similar regions (Olds and Milner, 1954). Indeed, many studies have since shown that stimulation of serotonin-rich nuclei of the brain (i.e. median and dorsal raphe nuclei) can sustain intracranial self-stimulation (ICSS) (e.g. Broadbent and Greenshaw, 1985, Van Der Kooy et al., 1978). At least one study has demonstrated that perfusion of 5-HT close to the ventral tegmental area (a key area of the mesolimbic system which contains the cell bodies of mesocorticolimbic dopamine-containing projections) increases rates of ICSS of the medial forebrain bundle (Redgrave and Horrell, 1976). Paradoxically, selective lesioning of serotonergic cells appears to facilitate ICSS (Poschel et al., 1974). In addition, increased reward is seen with conditioned place preference following administration of drugs that increase brain 5-HT (Subhan et al., 2000), although increases in 5-HT generally correlate with decreases in self-administration (Lyness et al., 1980, Yu et al., 1986). These conflicting, and often difficult to interpret, results are likely due to the high number of 5-HT targets (which can be located on multiple cell types within and/or across brain regions – resulting in the potential for each receptor subtype to have opposing effects on reward; for an excellent narrative review on the history of 5-HT and the discovery of its receptor subtypes, see Green, 2006). The use of behavioural models with reward-selective measures are discussed below in Section 2.4.
The rapid growth of knowledge around existing 5-HT receptor subtypes, in conjunction with improved techniques and a more collaborative environment among fields encompassing biomedical research and chemical engineering, allowed for the rapid development of numerous ligands in the 1980s and 1990s (Green, 2006). The early identification of 5-HT receptor selective ligands – such as mianserin and eltoprazine, which were originally considered antagonists for the 5-HT2 receptor family, though eltoprazine was also known to be an agonist for the 5-HT1B receptor – allowed for a more detailed investigation of 5-HT receptor subtype function (Peroutka and Snyder, 1981, Schipper et al., 1990). Although some studies using these compounds reported reward-related findings consistent with more recent studies (for instance, the finding by Risinger and Oakes (1996) showing that mianserin did not induce place conditioning alone, but did enhance alcohol-induced place preference), others had seemingly contradictory findings (Rocha et al., 1993). These were later clarified through the use of additional, more selective, ligands (e.g. Mosher et al., 2005, Hayes et al., 2009a, Hayes et al., 2009b), and an improved knowledge of 5-HT receptor pharmacology.
Taken together, these data underscore the need to clarify the role of 5-HT in reward-related processing and behaviour. An increase in the number and development of much more selective pharmacological agonists and antagonists, and refinement of reward-related behavioural measures, over the past two decades has been essential to this endeavour. As a result of this advancement of knowledge on many fronts (e.g. multiple, readily available, selective ligands; improved understanding of 5-HT receptor subtypes) this is perhaps the first opportunity to extensively review the literature on this topic – although the authors’ acknowledge that future advancements may result in conceptual revisions to the present work. Nonetheless, this review aims to add clarity and insight to our current understanding of the role of 5-HT receptor subtypes in reward-related behaviour and to underscore the relevant contents (e.g. subtype function and localization, drug delivery parameters, species under investigation) and contexts (e.g. type of reward-related paradigm used; mechanism of drug used to produce reward, such as cocaine vs. ethanol) which are likely important in this regard.
Section snippets
Inclusion criteria
We aimed to identify all studies which focused on the functionally selective agonism or antagonism of 5-HT receptor subtypes (discussed briefly below in Section 2.3) on the reward-related paradigms of intracranial self-stimulation (ICSS), self-administration, and place conditioning (described briefly below in Section 2.4) through numerous PubMed searches and subsequent searches through relevant reference sections and review papers.
In order to clarify the role of specific 5-HT receptor subtypes
Results of review
The specific results of the review are outlined in three tables. All tables use the symbols and to identify agonists and antagonists, respectively. Table 2A lists the results of studies that looked at 5-HT receptor subtype function in intracranial self-stimulation (ICSS), note that the symbol is used to identify studies that do not clearly distinguish between reward and motor effects; Table 2B lists the results related to self-administration; Table 2C lists the results related to place
Discussion
This review compared the roles of 5-HT receptor subtypes, using pharmacologically selective manipulations, in animal models of reward-related behaviour (i.e. intracranial self-stimulation (ICSS), self-administration, place conditioning). These behavioural models were chosen as they involve the direct activation of the brain's reward-related circuitry (either through electrical or receptor stimulation), have reward-selective measures, and are sensitive to the reinforcing properties of drugs of
Acknowledgements
The authors would like to generously acknowledge the initial contributions made by Robert Clements and Tera Mosher in providing summaries of some of the early studies referred to in this review. This work was funded by the Canadian Institutes of Health Research (A.J.G.). D.J.H. was the recipient of a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and a CIHR Postdoctoral Fellowship during the course of this work.
References (267)
- et al.
The serotonin-1A receptor in anxiety disorders
Biol. Psychiatry
(2009) - et al.
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Pharmacol. Ther.
(2007) - et al.
Buspirone fails to affect cocaine-induced conditioned place preference in the mouse
Pharmacol. Biochem. Behav.
(1997) - et al.
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
Pharmacol. Ther.
(2009) - et al.
A review of central 5-HT receptors and their function
Neuropharmacology
(1999) - et al.
Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats
Alcohol
(1994) - et al.
Physiological and therapeutic relevance of constitutive activity of 5-HT2A and 5-HT2C receptors for the treatment of depression
Prog. Brain Res.
(2008) - et al.
Parsing reward
Trends Neurosci.
(2003) - et al.
Dissecting components of reward: ‘liking’ ‘wanting’, and learning
Curr. Opin. Pharmacol.
(2009) - et al.
5-HT3 receptor antagonist, tropisetron, does not influence ethanol-induced conditioned taste aversion and conditioned place aversion
Alcohol
(1997)
MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference
Pharmacol. Biochem. Behav.
Activation of 5-HT1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro
Brain Res.
Co-localization of 5-HT1B- and 5-HT1D receptor mRNA in serotonergic cell bodies in guinea pig dorsal raphe nucleus: a double labeling in situ hybridization histochemistry study
Neurosci. Lett.
3,4 methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system
Pharmacol. Res.
Effects of quipazine and of tryptamine on self-stimulation of median raphe nucleus and of lateral hypothalamus in rats
Pharmacol. Biochem. Behav.
Distribution of serotonin 5-HT2C receptors in the ventral tegmental area
Neuroscience
Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release
Alcohol
The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes
Eur. J. Pharmacol.
5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning
Eur. J. Pharmacol.
Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin
Brain Res.
Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists
Pharmacol. Biochem. Behav.
5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats
Pharmacol. Biochem. Behav.
Central 5-HT3 receptors in P and in AA alcohol-preferring rats: an autoradiographic study
Brain Res. Bull.
5-HT(7) receptors in the modulation of cognitive processes
Behav. Brain Res.
Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS
Neuropharmacology
Serotoninergic regulation of emotional and behavioural control processes
Trends Cogn. Sci.
Nicotine self-administration and locomotor activity are not modified by the 5-HT3 antagonists ICS 205-930 and MDL 72222
Pharmacol. Biochem. Behav.
Serotonin: a regulator of neuronal morphology and circuitry
Trends Neurosci.
Ondansetron, given during the acute cocaine withdrawal, attenuates oral cocaine self-administration
Eur. J. Pharmacol.
Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration
Neuropsychopharmacology
m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors
Neuroscience
SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system
Neuropharmacology
Serotonin type-1A receptor imaging in depression
Nucl. Med. Biol.
Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system
Neuroscience
Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine
Biol. Psychiatry
New 5-HT(1A) receptor ligands containing a N′-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation
Bioorg. Med. Chem. Lett.
Activation of 5-HT(1B) receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule
Pharmacol. Biochem. Behav.
Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding
Neuropsychopharmacology
Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation
Pharmacol. Biochem. Behav.
5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine
Neuropharmacology
Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system
Brain Res.
Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems
Eur. J. Pharmacol.
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input
Neuroscience
Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential
Trends Pharmacol. Sci.
Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists
Psychopharmacology (Berl.)
Differential effects of intra-midbrain raphe and systemic 8-OH-DPAT on VTA self-stimulation thresholds in rats
Psychopharmacology (Berl.)
An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat
J. Comp. Neurol.
5-HT(1B) receptors in nucleus accumbens efferents enhance both rewarding and aversive effects of cocaine
Eur. J. Neurosci.
Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward
Neuropsychopharmacology
Fine-tuning serotonin(2c) receptor function in the bra molecular functional implications
Neuropharmacology
Cited by (123)
Serotonin 4 receptor brain binding and oxytocin-promoted affective and social cognition in healthy women – A randomized controlled trial
2024, Comprehensive PsychoneuroendocrinologyNeuroendocrine hormones and signaling systems in sea cucumbers
2023, The World of Sea Cucumbers: Challenges, Advances, and InnovationsAversive motivation and cognitive control
2022, Neuroscience and Biobehavioral ReviewsCitation Excerpt :These diverse processes may be largely related to the numerous (at minimum 14) serotonin receptors in the brain (Carhart‐Harris, 2018; Carhart-Harris and Nutt, 2017; Cools et al., 2008a; Cowen, 1991; Homberg, 2012), making it challenging to map serotonin’s specific role in motivational and cognitive processing. Prior work has shown that serotonin is linked to reward and punishment processing (Cohen et al., 2015; Hayes and Greenshaw, 2011; Kranz et al., 2010), coordinating defense mechanisms (Deakin and Graeff, 1991; Graeff, 2004), behavioral suppression (Soubrié, 1986), aversive learning (Cools et al., 2008b; Daw et al., 2002; Dayan and Huys, 2008; Ogren, 1982), cognitive flexibility (Clarke et al., 2004, 2005; Matias et al., 2017), impulsivity (Desrochers et al., 2020; Ranade et al., 2014), and motor control (Jacobs and Fornal, 1993; Wei et al., 2014), to name a few. Perhaps one of the greatest challenges for developing a unified theory of 5-HT’s functional role relates to the observation that different 5-HT pathways mediate distinct adaptive responses to aversive outcomes (Deakin, 2013).
Behavioral neuroscience of aggression
2021, Encyclopedia of Behavioral Neuroscience: Second EditionSerotonergic regulation of the dopaminergic system: Implications for reward-related functions
2021, Neuroscience and Biobehavioral ReviewsCitation Excerpt :In fact, different populations have been identified that transmit 5-HT only, glutamate-only or co-transmit 5-HT and glutamate (Qi et al., 2014; Wang et al., 2019); possibly having different implications in behavioral expression. Critically, there are different 5-HT receptors present in the VTA and their expression depends on the neuronal type (i.e. DA vs non-DA neurons; for extensive reviews, see (De Deurwaerdere and Di Giovanni, 2017; Hayes and Greenshaw, 2011)). 5-HT1A, 5-HT2A, 5-HT2C and 5-HT3 are mostly expressed in DA neurons while 5 H T1A; 5-HT1B; 5-HT2A; 5 H T2C; 5 H T4−3; 5 H T 6 are expressed on non-DA cells, presumably GABAergic cells in the VTA.
Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence
2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry